SRX Global to acquire CERo Therapeutics via stock deal

SRX Global signed a stock purchase agreement to acquire CERo Therapeutics from CERo Therapeutics Holdings, issuing $1.0 million of its common stock at closing, forgiving/canceling an $8.25 million senior secured note plus accrued amounts, and assuming about $1.56 million of liabilities.